Il y a eu 24 transactions d'initiés récentes enregistrées pour MBX Biosciences, Inc. Common Stock (MBX), dont 19 achats et 2 ventes. Le total des achats d'initiés s'élève à $25.13M et le total des ventes d'initiés à $1.05M.
Les initiés notables ayant une activité récente comprennent Smither John W, Hawryluk P. Kent, Bartram Richard. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — MBX
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-16 |
Smither John W |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-03-13 |
Hawryluk P. Kent |
President & CEO |
Achat Informatif |
18,500 |
$28.41 |
$525.66K |
486,777 |
| 2026-02-26 |
Hawryluk P. Kent |
President & CEO |
Exercice d'Options (Vente) |
28,768 |
$16.00 |
$460.29K |
91,668 |
| 2026-02-02 |
Hawryluk P. Kent |
President & CEO |
Attribution de RSU |
164,500 |
$39.07 |
$6.43M |
164,500 |
| 2026-02-02 |
Bartram Richard |
Chief Financial Officer |
Attribution de RSU |
15,000 |
- |
- |
15,000 |
| 2026-02-02 |
Azoulay Salomon |
Chief Medical Officer |
Attribution de RSU |
15,000 |
- |
- |
15,000 |
| 2026-01-20 |
Stelzer Laurie |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-01-20 |
Stelzer Laurie |
Director |
Attribution de RSU |
32,000 |
$43.14 |
$1.38M |
32,000 |
| 2025-11-22 |
Hoerter Steven L. |
Director |
Attribution de RSU |
8,000 |
$27.08 |
$216.64K |
8,000 |
| 2025-11-06 |
Hoerter Steven L. |
Director |
Attribution de RSU |
100,000 |
$24.74 |
$2.47M |
100,000 |
| 2025-10-24 |
Hawryluk P. Kent |
President & CEO |
Exercice d'Options (Vente) |
182,859 |
$3.25 |
$594.29K |
129,708 |
| 2025-10-20 |
Hawryluk P. Kent |
President & CEO |
Achat Informatif |
20,000 |
$13.64 |
$272.79K |
468,277 |
| 2025-10-17 |
Hoerter Steven L. |
Director |
Achat Informatif |
20,000 |
$13.25 |
$264.98K |
20,000 |
| 2025-09-26 |
Heron Patrick J |
10 Percent Owner |
Achat Informatif |
666,666 |
$18.00 |
$12M |
5,219,440 |
| 2025-06-05 |
Cornelius James M |
Director |
Attribution de RSU |
16,000 |
$11.86 |
$189.76K |
16,000 |
| 2025-06-05 |
Mathers Edward T |
10 Percent Owner |
Attribution de RSU |
16,000 |
$11.86 |
$189.76K |
16,000 |
| 2025-06-05 |
Heron Patrick J |
10 Percent Owner |
Attribution de RSU |
16,000 |
$11.86 |
$189.76K |
16,000 |
| 2025-06-05 |
Pescovitz Ora H. |
Director |
Attribution de RSU |
16,000 |
$11.86 |
$189.76K |
16,000 |
| 2025-06-05 |
Hoerter Steven L. |
Director |
Attribution de RSU |
16,000 |
$11.86 |
$189.76K |
16,000 |
| 2025-06-05 |
Aynechi Tiba |
Director |
Attribution de RSU |
16,000 |
$11.86 |
$189.76K |
16,000 |
| 2025-06-05 |
Ryder Steven |
Director |
Attribution de RSU |
16,000 |
$11.86 |
$189.76K |
16,000 |
| 2025-04-08 |
Pescovitz Ora H. |
Director |
Achat Informatif |
7,693 |
$5.89 |
$45.31K |
24,329 |
| 2025-04-07 |
Hoerter Steven L. |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-04-07 |
Hoerter Steven L. |
Director |
Attribution de RSU |
32,000 |
$6.00 |
$192K |
32,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi